Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Phase II Multicenter Trial To Evaluate the Safety and Efficacy of Low-Toxicity Treosulfan/Fludarabine Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia.

Blood (2007) 110 (11): 621.

https://doi.org/10.1182/blood.V110.11.621.621

Published: 2007

Journal Articles

The Bi-Specific T-Cell Enhancer (BiTE) MT103 (MEDI-538) Induces Clinical Responses in Heavily Pre-Treated NHL Patients: Update from the Ongoing Phase I Study MT103-104.

Ralf Bargou, MD, R. Noppeney, MD, M. Schuler, MD, G. Hess, MD, Ch Gerecke, MD, F. Zettl, MD, J. Birkmann, MD, A. Viardot, MD, P. Kirchinger, P. Baeuerle, PhD, C. Reinhardt, MD, M. Klinger, M. Libicher, MD, M. Goebeler, MD, H. Einsele, MD, P. Kufer, MD, G. Zugmaier, MD, E. Leo, MD

Blood (2006) 108 (11): 693.

https://doi.org/10.1182/blood.V108.11.693.693

Published: 2006

Journal Articles

Uptake of New Therapeutics in the Treatment of Multiple Myeloma (MM) in Germany (GER) - Results from a Representative Multicentre Treatment Survey 2006.

Ralf Angermund, MD, W. Knauf, MD, M. Freund, MD, M. Nowrousian, MD, H. Einsele, MD, H. Goldschmidt, MD, W. Berdel, MD, W. Poenisch, MD, C. Straka, MD, L. Kellermann, H. Pliskat, PhD

Blood (2006) 108 (11): 5110.

https://doi.org/10.1182/blood.V108.11.5110.5110

Published: 2006

Journal Articles

A Multicenter Phase I/II Trial Evaluating the Safety and Efficacy of Lenalidomide [Revlimidä (R), CC-5013] in Combination with Doxorubicin and Dexamethasone (RAD) in Patients with Relapsed or Refractory Multiple Myeloma.

C. Gerecke, S. Knop, M.S. Topp, S. Kotkiewitz, H. Gollasch, P. Liebisch, G. Hess, K. Watters, H. Einsele, R.C. Bargou

Blood (2005) 106 (11): 5136.

https://doi.org/10.1182/blood.V106.11.5136.5136

Published: 2005

Journal Articles

Role of Bortezomib in the Treatment of Multiple Myeloma - First Results from a Representative Multicentre Treatment Survey in Germany (GER).

Ralf Angermund, W. Knauf, M. Freund, M. R. Nowrousian, H. Einsele, H. Goldschmidt, W. E. Berdel, W. Poenisch, C. Straka, L. Kellermann, S. Bammer

Blood (2005) 106 (11): 5156.

https://doi.org/10.1182/blood.V106.11.5156.5156

Published: 2005

Journal Articles

Treatment Situation for Newly Diagnosed Multiple Myeloma (MM) Patients in Germany (GER)- First Results from a Representative Multicentre Treatment Survey.

Mathias R.F. Freund, W. Knauf, H. Goldschmidt, H. Einsele, M. R. Nowrousian, W. E. Berdel, W. Poenisch, C. Straka, L. Kellermann, S. Bammer, R. Angermund

Blood (2005) 106 (11): 5158.

https://doi.org/10.1182/blood.V106.11.5158.5158

Published: 2005

Journal Articles

Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation

H Einsele, G Ehninger, H Hebart, KM Wittkowski, U Schuler, G Jahn, P Mackes, M Herter, T Klingebiel, J Loffler

Blood (1995) 86 (7): 2815–2820.

https://doi.org/10.1182/blood.V86.7.2815.2815

Published: 1995

Journal Articles

Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation

H Einsele, G Ehninger, M Steidle, I Fischer, S Bihler, F Gerneth, A Vallbracht, H Schmidt, HD Waller, CA Muller

Blood (1993) 82 (5): 1672–1678.

https://doi.org/10.1182/blood.V82.5.1672.1672

Published: 1993

Journal Articles

Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique

H Einsele, M Steidle, A Vallbracht, JG Saal, G Ehninger, CA Muller

Blood (1991) 77 (5): 1104–1110.

https://doi.org/10.1182/blood.V77.5.1104.1104

Published: 1991

NARROW

Phase II Multicenter Trial To Evaluate the Safety and Efficacy of Low-Toxicity Treosulfan/Fludarabine Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia.

The Bi-Specific T-Cell Enhancer (BiTE) MT103 (MEDI-538) Induces Clinical Responses in Heavily Pre-Treated NHL Patients: Update from the Ongoing Phase I Study MT103-104.

Uptake of New Therapeutics in the Treatment of Multiple Myeloma (MM) in Germany (GER) - Results from a Representative Multicentre Treatment Survey 2006.

A Multicenter Phase I/II Trial Evaluating the Safety and Efficacy of Lenalidomide [Revlimidä (R), CC-5013] in Combination with Doxorubicin and Dexamethasone (RAD) in Patients with Relapsed or Refractory Multiple Myeloma.

Role of Bortezomib in the Treatment of Multiple Myeloma - First Results from a Representative Multicentre Treatment Survey in Germany (GER).

Treatment Situation for Newly Diagnosed Multiple Myeloma (MM) Patients in Germany (GER)- First Results from a Representative Multicentre Treatment Survey.

Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation

Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation

Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only